Australia raised A$5.68 billion (US$4.9 billion) selling shares of Medibank Private Ltd in the country’s second-largest initial public offering (IPO).
The government sold about 2.7 billion shares in the nation’s biggest health insurer at A$2.15 apiece for institutional investors and A$2 for individuals, Australian Finance Minister Mathias Cormann said on a conference call on Sunday.
The sale brought the total amount raised by Australian IPOs this year to A$15.9 billion, the highest since at least 1997, data compiled by Bloomberg show.
“It has been a very strong year for Australia IPOs, despite what has happened with market volatility in the last three to four months,” Evan Lucas, a markets strategist in Melbourne at IG Ltd, said by phone. “The support from equity markets in 2013 and 2014 is a huge contrast to the previous two years when things were very slow.”
Australian Prime Minister Tony Abbott is cutting spending and selling assets as he seeks to rein in a budget deficit that swelled to A$48.5 billion in the year through June.
Australia’s benchmark stock index has slipped 4.8 percent since Aug. 29, when some details of the IPO were announced, amid increasing signs that economies from Japan to Europe are losing momentum.
The government had raised the indicative IPO price range to A$2 to A$2.30 a share, citing strong demand from institutional investors. The shares were previously marketed at A$1.55 to A$2 apiece. The price for individual investors was capped at A$2.
“The government has looked after the moms and dads in granting retail investors a premium when the stock starts trading tomorrow [today],” Lucas said. “Because of the scalebacks, institutions will be underweight and there is likely to be solid buying tomorrow as they top up their holdings.”
The sale price values Medibank at 22.9 times estimated earnings for the year ending June next year, according to data compiled by Bloomberg. NIB Holdings Ltd, the nation’s only other listed health insurer, trades at 19.3 times profit on that basis.
“The offer has generated a very high level of demand both from domestic and offshore institutional investors,” Cormann said from Perth on Sunday.
Medibank “will be more flexible in pursuing growth opportunities into the future, they will have better access to capital markets and they will have the opportunity to perform and do the best they can without having the restrictions of government ownership imposed on them,” he said.
Abbott’s government in April hired Macquarie Group Ltd, Deutsche Bank AG and Goldman Sachs Group Inc to manage the Medibank IPO. It has also assigned advisers to scoping studies on other asset sales including Defence Housing Australia, the Royal Australian Mint and the Australian Securities and Investments Commission’s registry business.
The Medibank offering surpassed the A$4.3 billion raised when the government of Queensland state sold a stake in rail operator Aurizon Holdings Ltd in 2010, according to data compiled by Bloomberg. It is Australia’s biggest IPO since Telstra Corp’s sale in 1997.
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
ROW: A probe would determine if the rights of shareholders who were not allowed to vote yesterday had been violated, while the stock exchange also wants answers The election of board directors yesterday at Tatung Co (大同) sparked controversy after the company blocked some institutional and individual shareholders from participating in the general shareholders’ meeting, prompting the Financial Supervisory Commission (FSC) to announce that the vote would be investigated. Lin Kuo Wen-yen (林郭文艷) was re-elected as chairwoman of the household-appliance maker’s nine-member board, but prior to the vote she announced that several shareholders would not have voting rights. They were being denied a vote because they had contravened the Business Mergers and Acquisitions Act (企業併購法), and the Act Governing Relations Between the People of the Taiwan Area and